David C Uprichard - Net Worth and Insider Trading
David C Uprichard Net Worth
The estimated net worth of David C Uprichard is at least $640 dollars as of 2024-12-14. David C Uprichard is the Director of aTyr Pharma Inc and owns about 209 shares of aTyr Pharma Inc (ATYR) stock worth over $640. David C Uprichard is also the Director of Cyclacel Pharmaceuticals Inc and owns about 1 shares of Cyclacel Pharmaceuticals Inc (CYCC) stock worth over $0. Details can be seen in David C Uprichard's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David C Uprichard has not made any transactions after 2013-05-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David C Uprichard
David C Uprichard Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David C Uprichard owns 1 companies in total, including Cyclacel Pharmaceuticals Inc (CYCC) .
Click here to see the complete history of David C Uprichard’s form 4 insider trades.
Insider Ownership Summary of David C Uprichard
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CYCC | Cyclacel Pharmaceuticals Inc | 2006-09-14 | director |
David C Uprichard Latest Holdings Summary
David C Uprichard currently owns a total of 2 stocks. Among these stocks, David C Uprichard owns 209 shares of aTyr Pharma Inc (ATYR) as of May 29, 2013, with a value of $640 and a weighting of 99.94%. David C Uprichard also owns 1 shares of Cyclacel Pharmaceuticals Inc (CYCC) as of September 14, 2006, with a value of $0 and a weighting of 0.06%.
Latest Holdings of David C Uprichard
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ATYR | aTyr Pharma Inc | 2013-05-29 | 209 | 3.06 | 640 |
| CYCC | Cyclacel Pharmaceuticals Inc | 2006-09-14 | 1 | 0.36 | 0 |
Holding Weightings of David C Uprichard
David C Uprichard Form 4 Trading Tracker
According to the SEC Form 4 filings, David C Uprichard has made a total of 0 transactions in aTyr Pharma Inc (ATYR) over the past 5 years. The most-recent trade in aTyr Pharma Inc is the sale of 144 shares on May 29, 2013, which brought David C Uprichard around $148,820.
According to the SEC Form 4 filings, David C Uprichard has made a total of 0 transactions in Cyclacel Pharmaceuticals Inc (CYCC) over the past 5 years. The most-recent trade in Cyclacel Pharmaceuticals Inc is the acquisition of 0 shares on September 14, 2006, which cost David C Uprichard around $5,683.
Insider Trading History of David C Uprichard
- 1
David C Uprichard Trading Performance
GuruFocus tracks the stock performance after each of David C Uprichard's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David C Uprichard is 28.15%. GuruFocus also compares David C Uprichard's trading performance to market benchmark return within the same time period. The performance of stocks bought by David C Uprichard within 3 months outperforms 3 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David C Uprichard's insider trading performs compared to the benchmark.
Performance of David C Uprichard
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -4.86 | | | | | |
| Relative Return to S&P 500(%) | -8.67 | | | | | |
David C Uprichard Ownership Network
Ownership Network List of David C Uprichard
Ownership Network Relation of David C Uprichard
David C Uprichard Owned Company Details
What does Cyclacel Pharmaceuticals Inc do?
Who are the key executives at Cyclacel Pharmaceuticals Inc?
David C Uprichard is the director of Cyclacel Pharmaceuticals Inc. Other key executives at Cyclacel Pharmaceuticals Inc include director & President & C.E.O. Spiro Rombotis , director & E.V.P. & Finance & C.O.O. Paul Mcbarron , and Chief Medical Officer Mark Kirschbaum .
Cyclacel Pharmaceuticals Inc (CYCC) Insider Trades Summary
Over the past 18 months, David C Uprichard made no insider transaction in Cyclacel Pharmaceuticals Inc (CYCC). Other recent insider transactions involving Cyclacel Pharmaceuticals Inc (CYCC) include a net purchase of 6,070 shares made by Spiro Rombotis , and a net purchase of 1,886 shares made by Paul Mcbarron .
In summary, during the past 3 months, insiders sold 0 shares of Cyclacel Pharmaceuticals Inc (CYCC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cyclacel Pharmaceuticals Inc (CYCC) were sold and 7,956 shares were bought by its insiders, resulting in a net purchase of 7,956 shares.
Cyclacel Pharmaceuticals Inc (CYCC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cyclacel Pharmaceuticals Inc Insider Transactions
David C Uprichard Mailing Address
Above is the net worth, insider trading, and ownership report for David C Uprichard. You might contact David C Uprichard via mailing address: 12 Pine Street, Philadelphia Pa 19106.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
